Andrei N. Vzorov

Moscow, MOW 119234, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Virus-Like Particles Carrying HIV-1 Env with a Modulated Glycan Composition

Virus-Like Particles Carrying HIV-1 Env with a Modulated Glycan Composition

Journal: Molekuliarnaia biologiia

Published: November 24, 2023

Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41.

Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41.

Journal: mBio

Published: January 25, 2022

Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses

Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses

Journal: Molekuliarnaia biologiia

Published: March 04, 2021

Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses.

Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses.

Journal: Molecular biology

Published: March 04, 2021

Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination

Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination

Journal: Molekuliarnaia biologiia

Published: March 26, 2017

"Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env".

"Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env".

Journal: Archives of virology

Published: February 17, 2016

An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity.

An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity.

Journal: Acta virologica

Published: October 06, 2015

VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties

VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties

Journal: Molekuliarnaia biologiia

Published: September 29, 2015

Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.

Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.

Journal: Virology

Published: July 09, 2015

Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.

Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.

Journal: Retrovirology

Published: September 20, 2007

Showing 1-10 of 10

Last Updated: 09/26/2026